Modification of BM-MSC exosomes by transfecting miR-150-5p suppresses the angiogenesis and hyperplasia of FLS in RA patients by reducing the expression of MMP-14 and vascular endothelial growth factor (VEGF) [246]. This evidence concerns the gene VEGFA and rheumatoid arthritis.